UOC
SGYP

UBS O'Connor’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History

UBS O'Connor’s Portfolio SGYP Stock Details SGYP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-71,929
Closed -$324K – 528
2013
Q3 		$324K Sell
71,929
-105,521
-59% -$473K 0.01% 343
2013
Q2 		$756K Buy
+177,450
New +$892K 0.01% 392

Other funds holding SGYP

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
WSA
Wall Street Associates Lajolla, California $151M AUM 30.3% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

UBS O'Connor's SGYP Position: Q4 2013 in Review

UBS O'Connor sold out of Synergy Pharmaceuticals, Inc Common Stock (SGYP) in Q4 2013, closing a stake of 71,929 shares — an estimated $324K sold.

UBS O'Connor first reported a position in SGYP in Q2 2013 and held it in 2 quarters. The position peaked at $756K in Q2 2013. 72 funds tracked by Wall St. Rank hold SGYP as of Q4 2013.

  • UBS O'Connor reported no remaining Synergy Pharmaceuticals, Inc Common Stock position as of Q4 2013 after selling out during the quarter.
  • UBS O'Connor sold 71,929 Synergy Pharmaceuticals, Inc Common Stock shares in Q4 2013, an estimated $324K.
  • UBS O'Connor first reported a position in Synergy Pharmaceuticals, Inc Common Stock in Q2 2013 and held it in 2 quarters.
  • UBS O'Connor's Synergy Pharmaceuticals, Inc Common Stock position peaked at $756K in Q2 2013.
  • 72 funds tracked by Wall St. Rank held Synergy Pharmaceuticals, Inc Common Stock as of Q4 2013.

Based on UBS O'Connor's 13F filing for Q4 2013, filed 13 Feb 2014.